Cumberland Pharmaceuticals (CPIX) Free Cash Flow (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) reported Free Cash Flow of $387025.0 for Q1 2026, down 89.95% on a YoY basis from $3.9 million in Q1 2025, and up 12694.21% sequentially from $3025.0 in Q4 2025.
Cumberland Pharmaceuticals (CPIX) Free Cash Flow (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals (CPIX) has 17 years of Free Cash Flow data on file, last reported at $387025.0 in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow fell 89.95% year-over-year to $387025.0; the trailing twelve-month figure through Mar 2026 stood at $1.4 million (down 74.38% YoY), and the FY2025 full-year result was $4.8 million, up 812.39% from the prior year.
- Free Cash Flow climbed to $387025.0 in Q1 2026, from $3025.0 in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $5.2 million in Q2 2023 to a low of -$2.2 million in Q1 2024.
- A 5-year average of $1.1 million and a median of $817315.0 in 2025 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow sank 759.5% in 2023 and soared 276.79% in 2025, its largest moves.
- Tracing CPIX's Free Cash Flow over 5 years: stood at $3.8 million in 2022, then slumped by 73.85% to $991448.0 in 2023, then soared by 91.87% to $1.9 million in 2024, then plunged by 99.84% to $3025.0 in 2025, then soared by 12694.21% to $387025.0 in 2026.
- Business Quant data shows CPIX's Free Cash Flow at $387025.0 in Q1 2026, $3025.0 in Q4 2025, and $163392.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -208.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 291.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -373.37 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 363.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 348.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 144.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -38.00 Mn |
| 10 | Cumberland Pharmaceuticals | 104.57 Mn | 93.23 Mn | 7.20 Mn | 387,025.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 387,025.00 |
| Mar 31, 2026 | 387,025.00 |
| Dec 31, 2025 | 3,025.00 |
| Dec 31, 2025 | 3,025.00 |
| Sep 30, 2025 | 163,392.00 |
| Sep 30, 2025 | 163,392.00 |
| Jun 30, 2025 | 817,315.00 |
| Jun 30, 2025 | 817,315.00 |
| Mar 31, 2025 | 3.85 Mn |
| Mar 31, 2025 | 3.85 Mn |
| Dec 31, 2024 | 1.90 Mn |
| Dec 31, 2024 | 1.90 Mn |
| Sep 30, 2024 | 460,124.00 |
| Sep 30, 2024 | 460,124.00 |
| Jun 30, 2024 | -862,838.00 |
| Jun 30, 2024 | -862,838.00 |
| Mar 31, 2024 | -2.18 Mn |
| Mar 31, 2024 | -2.18 Mn |
| Dec 31, 2023 | 991,448.00 |
| Dec 31, 2023 | 991,448.00 |